HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Margot Chima Selected Research

Margot Chima Research Topics

Disease

4Psoriasis (Pustulosis Palmaris et Plantaris)
02/2020 - 09/2018
3Alopecia Areata
10/2022 - 01/2019
3Atopic Dermatitis (Atopic Eczema)
01/2022 - 01/2019
2Ichthyosis (Xeroderma)
10/2022 - 02/2022
2Alopecia (Baldness)
10/2022 - 01/2022
2Infections
02/2022 - 11/2020
1Familial Perifolliculitis Capitis Abscedens Et Suffodiens
03/2022
1Mycoses (Diseases, Fungus)
02/2022
1Erythema
11/2020
1Cicatrix (Scar)
11/2020
1Dermatitis
11/2020
1Acneiform Eruptions
11/2020
1Skin Diseases (Skin Disease)
01/2019
1Vitiligo
01/2019
1Inflammation (Inflammations)
09/2018

Drug/Important Bio-Agent (IBA)

4Interleukin-17 (Interleukin 17)IBA
02/2022 - 01/2019
2SaltsIBA
10/2022 - 01/2022
2dupilumabIBA
10/2022 - 01/2022
2secukinumabIBA
02/2022 - 01/2021
2CytokinesIBA
01/2019 - 09/2018
1Antimicrobial PeptidesIBA
10/2022
1risankizumabIBA
03/2022
1Monoclonal AntibodiesIBA
01/2022
1Ointments (Pastes)IBA
02/2020
1Phosphodiesterase 4 InhibitorsIBA
02/2020
1crisaboroleIBA
02/2020
1Interleukin-22 (IL-22)IBA
01/2019
16-sulfo sialyl Lewis XIBA
01/2019
1brodalumabIBA
01/2019
1Biomarkers (Surrogate Marker)IBA
01/2019
1Interleukin-9 (Interleukin 9)IBA
01/2019
1Interleukin-13IBA
01/2019
1Tumor Necrosis Factor InhibitorsIBA
09/2018
1Adalimumab (Humira)FDA Link
09/2018
1Etanercept (Enbrel)FDA Link
09/2018
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2018
1Infliximab (Remicade)FDA Link
09/2018

Therapy/Procedure

1Aftercare (After-Treatment)
10/2022
1Lasers (Laser)
11/2020
1Therapeutics
01/2019